Why it matters
ACCESS is not a small demonstration in concept only; the accepted-applicant base indicates broad market participation and a potentially meaningful new adoption channel.
Decision implication
Map accepted organizations by track, geography, technology model, and partnership potential; identify who becomes an adoption gateway.
Who or what is affected
- CMS Innovation Center
- >150 accepted organizations
- technology vendors
- clinicians
- Medicare beneficiaries
Evidence and sources
E5 — official federal source
P4L distinguishes the sourced event from the interpretation above. Participation, funding, proposed policy, or program inclusion does not by itself establish clinical effectiveness.
What P4L is watching next
- Final participation
- new 2027 entrants
- organization performance
- directory usage.
Related proof records
- CLM-0001 — CMS ACCESS tests outcome-aligned payment for technology-supported chronic care in Original Medicare.
- CLM-0002 — CMS reported more than 150 organizations accepted to participate in ACCESS.
- CLM-0004 — ACCESS + TEMPO creates a practical bridge among payment, regulatory oversight, real-world evidence, and technology-supported chronic care.